MedTech News

Algorithm pinpoints potential disease-causing variants in non-coding regions of human genome
Researchers from Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have successfully employed an algorithm to identify potential mutations which increase disease risk in the noncoding regions of our DNA, which make up the vast majority of the human genome.

A new approach to asthma treatment: Harnessing the liver to reprogram the immune system
For millions of people around the world, asthma is more than just a breathing problem—it is a chronic and often debilitating condition caused by the immune system’s exaggerated response to harmless airborne particles.

Low-intensity electrical pulses could help the immune system fight cancer
High-intensity electrical pulses have been medically used to destroy tumors while sparing healthy tissue. But lower-intensity pulses may have a different effect—they reshape the battlefield, making tumors more vulnerable to the body’s own defenses.

Medline Secures FDA Clearance for REFLEX® HYBRID Nitinol Implants
New implants aim to enhance outcomes in foot and ankle surgeries through advanced material technology.

CardioFocus reports successful pulsed field ablation cases
CardioFocus announced the completion of successful clinical cases with its QuickShot Nav large-area focal pulsed field ablation (PFA) catheter.

Precision Neuroscience wins FDA clearance for BCI cortical interface
Precision Neuroscience announced today that it received FDA 510(k) clearance for its Layer 7 cortical interface for BCI technology

Adagio Medical wins FDA breakthrough nod for cryoablation tech
Adagio Medical (Nasdaq:ADGM) announced today that it received FDA breakthrough device designation for its vCLAS cryoablation system

FDA Clearance and First in Human Use for SoloPace™ Temporary Pacing System for TAVR
SAN FRANCISCO, April 17, 2025 /PRNewswire/ — Solo Pace Incorporated, an emerging medical technology company, announced both FDA Clearance and First-In-Human use of their SoloPace Control System for temporary pacing in Transcatheter Aortic Valve Replacement (TAVR) procedures. With standardized workflows, the Control System is engineered to improve TAVR temporary pacing efficiency and reduce patient risks. Initial cases were completed this month at Scripps Clinic by Chief of Cardiology, Paul Teirstein, MD and Curtiss Stinis, MD.